David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPLK
526
CALL
DELISTED
Splunk Inc
SPLK
| $30.4M | 0.04% |
243,800
+39,100
| +19% | +$4.88M |
|
527
Simply Good Foods
SMPL
$970M
| $30.3M | 0.04% |
1,469,840
-118,477
| -7% | -$2.37M |
|
|
PS
528
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $30.1M | 0.04% |
+949,721
| New | +$28.1M |
|
529
First American
FAF
$7.38B
| $30M | 0.04% |
582,238
+126,818
| +28% | +$6.28M |
|
530
Innoviva
INVA
$1.52B
| $30M | 0.04% |
2,136,118
+179,798
| +9% | +$2.91M |
|
531
CALL
PepsiCo
PEP
$197B
| $29.9M | 0.04% |
+244,300
| New | +$27.8M |
|
532
Sysco
SYY
$40.1B
| $29.8M | 0.04% |
446,724
-9,040
| -2% | -$588K |
|
533
Wintrust Financial
WTFC
$10.3B
| $29.7M | 0.04% |
441,098
+82,631
| +23% | +$5.9M |
|
534
CALL
American Airlines Group
AAL
$9.02B
| $29.6M | 0.04% |
932,500
+155,200
| +20% | +$5.21M |
|
535
CALL
Oracle
ORCL
$410B
| $29.5M | 0.04% |
550,000
+337,400
| +159% | +$17.2M |
|
|
DOCU
536
DocuSign
DOCU
$11.9B
| $29.4M | 0.04% |
+568,073
| New | +$29M |
|
537
PUT
Valero Energy
VLO
$99.6B
| $29.4M | 0.04% |
346,800
-183,200
| -35% | -$15.1M |
|
538
Grand Canyon Education
LOPE
$3.85B
| $29.3M | 0.04% |
256,117
+6,380
| +3% | +$658K |
|
539
Itaú Unibanco
ITUB
$82.9B
| $29.3M | 0.04% |
4,571,509
-10,153,637
| -69% | -$71.8M |
|
540
Chegg
CHGG
$88.9M
| $29.2M | 0.04% |
767,256
+402,481
| +110% | +$14.7M |
|
541
Dropbox
DBX
$7.58B
| $29.2M | 0.04% |
1,340,518
+1,322,018
| +7,146% | +$30.8M |
|
542
Ciena
CIEN
$52.7B
| $29.1M | 0.04% |
780,238
+48,783
| +7% | +$1.89M |
|
543
Fortune Brands Innovations
FBIN
$5.37B
| $29.1M | 0.04% |
715,141
-178,785
| -20% | -$6.86M |
|
544
Bio-Rad Laboratories Class A
BIO
$10.2B
| $29.1M | 0.04% |
95,196
-133,900
| -58% | -$36.1M |
|
545
BlackLine
BL
$1.86B
| $29M | 0.04% |
627,060
+180,538
| +40% | +$8.49M |
|
546
TE Connectivity
TEL
$58.6B
| $28.9M | 0.04% |
357,952
-371,277
| -51% | -$30M |
|
547
Western Digital
WDC
$157B
| $28.9M | 0.04% |
794,288
-688,594
| -46% | -$23.6M |
|
548
Telus
TU
$15.5B
| $28.8M | 0.04% |
1,557,400
-1,851,442
| -54% | -$32.7M |
|
549
PUT
Salesforce
CRM
$171B
| $28.8M | 0.04% |
182,100
-108,500
| -37% | -$16.8M |
|
|
CSOD
550
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $28.8M | 0.04% |
526,014
+1,993
| +0.4% | +$110K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.